Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Vetoron** is a dietary supplement combining **beta-carotene** (provitamin A, 3 mg per tablet), **alpha-tocopherol acetate** (vitamin E, 1.2 mg), and **ascorbic acid** (vitamin C, 20 mg), primarily recommended for frequently ill children to enhance immunity and provide antioxidant support. It leverages the synergistic anti-inflammatory, immunomodulatory, and antioxidant properties of these vitamins to protect against oxidative stress more effectively than individually. Administered orally as drops or tablets dissolved in water or drink once daily with meals, with dosing adjusted seasonally (e.g., 5-6 drops in summer, 10-11 in winter for adults); side effects may include skin yellowing from excess beta-carotene, resolving upon dose reduction.[1][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vetoron.